Repare Therapeutics Inc expected to post a loss of 72 cents a share - Earnings Preview

Repare Therapeutics

25/02/2023 03:08

* Repare Therapeutics Inc  RPTX.OQ   RPTX.O  is expected
to show a
rise in quarterly revenue when it reports  results on February
27 (estimated). 
    * The St-laurent Quebec-based  company is expected to report
 a
18.0% increase in revenue to $8.117 million from $6.88 million a
year ago, according to the mean estimate from 6 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Repare Therapeutics
Inc
is for a loss of 72 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Repare
Therapeutics Inc is $28​, above​ its last closing price
of $10.21. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.89       -0.89      1.71      Beat    292.6
 Jun. 30 2022  -0.84       -0.85      -0.91     Missed  -7.5
 Mar. 31 2022  -0.86       -0.86      -0.83     Beat    3​
 Dec. 31 2021  -0.74       -0.74      -0.70     Beat    5.4
 ​​Sep.        -0.71       -0.71      -0.83     Missed  -16.9
 30 2021                                                
 Jun. 30 2021  -0.60       -0.60      -0.71     Missed  -17.4​
 Mar. 31 2021  -0.51       -0.51      -0.58     Missed  -14.6
 Dec. 31 2020  -0.40       -0.39      -0.41     Missed  -3.8
 This summary was machine generated February 25 at 03:07 GMT. 
All figures in US dollars  unless otherwise stated